TrialThe Lancet. Infectious diseases2021

Safety and immunogenicity of inactivated poliovirus vaccine schedules for the post-eradication era: a randomised open-label, multicentre, phase 3, non-inferiority trial.

Ananda S Bandyopadhyay et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.